Evidence map›Paper›PMID 38030680›Full record

ArticleScientific reports2023

An arrayed CRISPR knockout screen identifies genetic regulators of GLUT1 expression.

Yajuan Shi, Ketaki A Katdare, Hyosung Kim, Jonah C Rosch, Emma H Neal, Sidney Vafaie-Partin, Joshua A Bauer, Ethan S Lippmann

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Yajuan Shi *Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Ketaki A Katdare *Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN, USA.
Hyosung KimDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Jonah C RoschDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Emma H NealDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Sidney Vafaie-PartinDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA.
Joshua A BauerVanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, TN, USA.
Ethan S LippmannDepartment of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, USA. ethan.s.lippmann@vanderbilt.edu.
Vanderbilt University · USVanderbilt Health · USVanderbilt University Medical Center · US

Funding

Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
iPSC-derived Neurovascular OrganoidsR01NS110665 · NINDS · VANDERBILT UNIVERSITY · PI LIPPMANN, ETHAN · 2020 to 2024
$2.5M
Cancer Pharmacologist and HTS ScientistR50CA211206 · NCI · VANDERBILT UNIVERSITY · PI Joshua A. Bauer · 2016 to 2026
$1.8M
NCI NIH HHS R50 CA211206NICHD NIH HHS P50 HD103537NIH HHS R01 NS110665NIH HHS R50 CA211206NINDS NIH HHS R01 NS110665
6 · The paper itself

Abstract

Glucose, a primary fuel source under homeostatic conditions, is transported into cells by membrane transporters such as glucose transporter 1 (GLUT1). Due to its essential role in maintaining energy homeostasis, dysregulation of GLUT1 expression and function can adversely affect many physiological processes in the body. This has implications in a wide range of disorders such as Alzheimer's disease (AD) and several types of cancers. However, the regulatory pathways that govern GLUT1 expression, which may be altered in these diseases, are poorly characterized. To gain insight into GLUT1 regulation, we performed an arrayed CRISPR knockout screen using Caco-2 cells as a model cell line. Using an automated high content immunostaining approach to quantify GLUT1 expression, we identified more than 300 genes whose removal led to GLUT1 downregulation. Many of these genes were enriched along signaling pathways associated with G-protein coupled receptors, particularly the rhodopsin-like family. Secondary hit validation confirmed that removal of select genes, or modulation of the activity of a corresponding protein, yielded changes in GLUT1 expression. Overall, this work provides a resource and framework for understanding GLUT1 regulation in health and disease.

Indexed as

Clustered Regularly Interspaced Short Palindromic RepeatsGlucoseBiological TransportCaco-2 CellsGlucose Transporter Type 1HumansGlucoseGlucose Transporter Type 1

Identifiers

PMID38030680
PMCPMC10687026
OpenAlexW4389140056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.